OKYO Pharma to Present at the Stifel 2026 Healthcare Conference

Summary by AI BETAClose X

OKYO Pharma (Nasdaq: OKYO) will present at the Stifel 2026 Healthcare Conference Nov 10–12 with the CEO presenting at 9:20 a.m. ET on Nov 12 and management available for one-on-one investor meetings; the live webcast will be archived for 90 days. The company disclosed that lead candidate urcosimod has enrolled first patients in the Phase 3 NEPTUNE trial, a material clinical development milestone and potential near-term catalyst. No financial figures, guidance, cash or debt metrics were provided in the announcement.

Disclaimer*

UK 100

Latest directors dealings